Dr. MA Lili (馬麗麗)

Research Output

  1. 2019
  2. Published

    Cytotoxic Plantium Complex, its Preparation and Therapeutic Use

    ZHU, G. & MA, L., 8 Oct 2019, Patent No. US10,435,424, Priority No. 15/371,532

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53)51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  3. Accepted/In press/Filed

    Cytotoxic Plantium Complex, its Preparation and Therapeutic Use

    ZHU, G. & MA, L., 3 Sep 2019, (Accepted/In press/Filed) Priority No. 16/558,546

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53)51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  4. 2018
  5. Published

    Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug

    Ma, L., Wang, N., Ma, R., Li, C., Xu, Z., Tse, M. & Zhu, G., 16 Jul 2018, In: Angewandte Chemie - International Edition. 57, 29, p. 9098-9102

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 31
    Check@CityULib
  6. Published

    Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer Prodrug

    Ma, L., Wang, N., Ma, R., Li, C., Xu, Z., Tse, M. & Zhu, G., 16 Jul 2018, In: Angewandte Chemie. 130, 29, p. 9236-9240

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Check@CityULib
  7. Published

    A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug

    Ma, L., Lin, X., Li, C., Xu, Z., Chan, C., Tse, M., Shi, P. & 1 others, Zhu, G., 5 Mar 2018, In: Inorganic Chemistry. 57, 5, p. 2917-2924

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 31
    Check@CityULib
  8. 2017
  9. Published

    Heterodinuclear Platinum-Ruthenium Complexes, Preparation Thereof and Therapeutic Use Thereof

    ZHU, G. & MA, L., 16 May 2017, Patent No. US9,650,402, Priority No. 14/829,934

    Research output: Patents, Agreements and Assignments (RGC: 51, 52, 53)51_Patents granted (CityU only, data source from KTO)

    Check@CityULib
  10. Published

    Halogenated PtIV Complexes from N-Halosuccinimide Oxidation of PtII Antitumor Drugs: Synthesis, Mechanistic Investigation, and Cytotoxicity

    Xu, Z., Li, C., Tong, Z., Ma, L., Tse, M. & Zhu, G., 27 Mar 2017, In: European Journal of Inorganic Chemistry. 2017, 12, p. 1706-1712

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 10
    Check@CityULib
  11. 2016
  12. Published

    Heterodinuclear Pt(IV)-Ru(II) anticancer prodrugs to combat both drug resistance and tumor metastasis

    Ma, L., Ma, R., Wang, Z., Yiu, S. & Zhu, G., 14 Sep 2016, In: Chemical Communications. 52, 71, p. 10735-10738

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 46
    Check@CityULib
  13. Presented

    Heterodinuclear Pt(IV)–Ru(II) complexes as potent bifunctional anticancer agents against both drug resistance and tumor metastasis

    MA, L., MA, R., WANG, Z. & ZHU, G., 23 Apr 2016, (Presented).

    Research output: Conference Papers (RGC: 31A, 31B, 32, 33)33_Other conference paper

    Check@CityULib
  14. Presented

    Monochalcoplatin, an attractive and significantly active Pt(IV) anticancer prodrug

    MA, R., LI, C., MA, L. & ZHU, G., 23 Apr 2016, (Presented).

    Research output: Conference Papers (RGC: 31A, 31B, 32, 33)33_Other conference paper

    Check@CityULib
  15. 2015
  16. Published

    Efficient co-delivery of a Pt(iv) prodrug and a p53 activator to enhance the anticancer activity of cisplatin

    Ma, R., Wang, Y., Yan, L., Ma, L., Wang, Z., Chan, H. C., Chiu, S. & 2 others, Chen, X. & Zhu, G., 7 May 2015, In: Chemical Communications. 51, 37, p. 7859-7862

    Research output: Journal Publications and Reviews (RGC: 21, 22, 62)21_Publication in refereed journalpeer-review

    Scopus citations: 20
    Check@CityULib
  17. Presented

    Chalcoplatin, a dual-targeting Pt(IV) anticancer prodrug containing p53 activators

    MA, L., MA, R. & ZHU, G., 18 Apr 2015, (Presented).

    Research output: Conference Papers (RGC: 31A, 31B, 32, 33)33_Other conference paper

    Check@CityULib
  18. 2014
  19. Presented

    Dual-targeting non-traditional platinum compounds and Pt-loaded inorganic nanoparticles to improve cisplatin’s anticancer activity

    ZHU, G., MA, R., MA, L. & WANG, B., 1 Dec 2014, (Presented).

    Research output: Conference Papers (RGC: 31A, 31B, 32, 33)33_Other conference paper

    Check@CityULib